Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Biol Macromol ; 230: 123272, 2023 Mar 01.
Article in English | MEDLINE | ID: mdl-36649864

ABSTRACT

Nanotechnology is a crucial technology in recent years has resulted in new and creative applications of nanomedicine. Polymeric nanoparticles have increasing demands in pharmaceutical applications and require high reproducibility, homogeneity, and control over their properties. Work explores the use of cashew phthalate gum (PCG) as a particle-forming polymer. PCG exhibited a pH-sensitive behavior due to the of acid groups on its chains, and control drug release. We report the development of nanoparticles carrying benznidazole. Formulations were characterized by DLS, encapsulation efficiency, drug loading, FTIR, pH-responsive behavior, release, and in vitro kinetics. Interaction between polymer and drug was an evaluated by molecular dynamics. Morphology was observed by SEM, and in vitro cytotoxicity by MTT assay. Trypanocidal effect for epimastigote and trypomastigote forms was also evaluated. NPs responded to the slightly basic pH, triggering the release of BNZ. In acidic medium, they presented small size, spherical shape, and good stability. It was indicated NP with enhanced biological activity, reduced cytotoxicity, high anti T. cruzi performance, and pH-sensitive release. This work investigated properties related to the development and enhancement of nanoparticles. PCG has specific physicochemical properties that make it a promising alternative to drug delivery, however, there are still challenges to be overcome.


Subject(s)
Anacardium , Nanoparticles , Trypanosoma cruzi , Reproducibility of Results , Nanoparticles/chemistry , Drug Liberation , Polymers/pharmacology , Hydrogen-Ion Concentration , Drug Carriers/pharmacology
2.
Int J Biol Macromol ; 193(Pt A): 450-456, 2021 Dec 15.
Article in English | MEDLINE | ID: mdl-34688680

ABSTRACT

Enoxaparin is an effective biological molecule for prevention and treatment of coagulation disorders. However, it is poorly absorbed in the gastrointestinal tract. In this study, we developed an Eudragit® L100 coated chitosan core shell nanoparticles for enoxaparin oral delivery (Eud/CS/Enox NPs) through a completely eco-friendly method without employing any high-energy homogenizer technique and any organic solvents. Spherical nanocarriers were successfully prepared with particle size lower than 300 nm, polydispersity index about 0.12 and zeta potential higher than +25 mV, entrapment efficiency greater than 95% and the in vitro release behavior confirms the good colloidal stability and the successful Eudragit® L100 coating process demonstrated by negligible cumulative enoxaparin release (<10%) when the particles are submitted to simulated gastric fluid conditions. Finally, we demonstrated that the core-shell structure of the particle influenced the drug release mechanism of the formulations, indicating the presence of the Eudragit® L100 on the surface of the particles. These results suggested that enteric-coating approach and drug delivery nanotechnology can be successfully explored as potential tools for oral delivery of enoxaparin.


Subject(s)
Chitosan/chemistry , Drug Carriers/chemistry , Enoxaparin/chemistry , Nanoparticles/chemistry , Drug Liberation , Particle Size
3.
Int J Biol Macromol ; 190: 801-809, 2021 Nov 01.
Article in English | MEDLINE | ID: mdl-34508723

ABSTRACT

We developed a new hydrophobic polymer based on angico gum (AG), and we produced new nanoparticles to expand the applications of natural polysaccharides in nanomedicine. Phthalate angico gum (PAG) was characterized by 1H NMR, FTIR, elementary analysis, solubility, XRD, and TG. PAG was a hydrophobic and semi-crystalline material, a relevant characteristic for drug delivery system applications. As a proof of concept, nevirapine (NVP) was selected for nanoparticles development. Plackett-Burman's experimental design was used to understand the influence of several factors in nanoparticles production. PAG proved to be a versatile material for producing nanoparticles with different characteristics. Optimized nanoparticles were produced using desirability parameters. NVP-loaded PAG nanoparticles formulation showed 202.1 nm of particle size, 0.23 of PDI, -17.1 of zeta potential, 69.8 of encapsulation efficiency, and promoted modified drug release for 8 h. Here we show that PAG presents as a promising biopolymer for drug delivery systems.


Subject(s)
Green Chemistry Technology , Nanoparticles/chemistry , Nanotechnology , Phthalic Acids/chemistry , Plant Gums/chemistry , Drug Liberation , Humans , Microscopy, Atomic Force , Molecular Weight , Nevirapine/pharmacology , Particle Size , Proton Magnetic Resonance Spectroscopy , Solubility , Spectroscopy, Fourier Transform Infrared , Thermogravimetry , X-Ray Diffraction
4.
Carbohydr Polym ; 254: 117226, 2021 Feb 15.
Article in English | MEDLINE | ID: mdl-33357841

ABSTRACT

Chemical modification of polysaccharides is an important approach for their transformation into customized matrices that suit different applications. Microwave irradiation (MW) has been used to catalyze chemical reactions. This study developed a method of MW-initiated synthesis for the production of phthalated cashew gum (Phat-CG). The structural characteristics and physicochemical properties of the modified biopolymers were investigated by FTIR, GPC, 1H NMR, relaxometry, elemental analysis, thermal analysis, XRD, degree of substitution, and solubility. Phat-CG was used as a matrix for drug delivery systems using benznidazole (BNZ) as a model drug. BNZ is used in the pharmacotherapy of Chagas disease. The nanoparticles were characterized by size, PDI, zeta potential, AFM, and in vitro release. The nanoparticles had a size of 288.8 nm, PDI of 0.27, and zeta potential of -31.8 mV. The results showed that Phat-CG has interesting and promising properties as a new alternative for improving the treatment of Chagas disease.


Subject(s)
Anacardium/chemistry , Drug Delivery Systems , Plant Gums/chemistry , Chagas Disease/drug therapy , Computer Simulation , Humans , In Vitro Techniques , Magnetic Resonance Spectroscopy , Microscopy, Atomic Force , Microwaves , Molecular Structure , Nanoparticles/chemistry , Nitroimidazoles/administration & dosage , Particle Size , Phthalic Acids/chemistry , Spectroscopy, Fourier Transform Infrared , Trypanocidal Agents/administration & dosage
5.
Int J Biol Macromol ; 165(Pt A): 279-290, 2020 Dec 15.
Article in English | MEDLINE | ID: mdl-32956746

ABSTRACT

In the present work, we investigated the minimal inhibitory concentration (MIC) against fungal strains (Fonsecaea pedrosoi, Microsporum canis, Candida albicans, Cryptococcus neoformans), and cytotoxicity to normal cell lines for modified red angico gum (AG) with eterifying agent N-chloride (3-chloro-2-hydroxypropyl) trimethylammonium (CHPTAC). Quaternized ammonium groups were linked to AG backbone using N-(3-chloro-2-hydroxypropyl) trimethylammonium chloride. The chemical features of the quaternized gum derivatives (QAG) were analyzed by: FTIR, elemental analysis, Zeta potential and gel permeation chromatography. The angico quaternizated gum presented a degree of substitution (DS) of 0.22 and Zeta potential of +36.43. For the antifungal test, it was observed that unmodified gum did not inhibit fungal growth. While, QAG inhibited the growth of most fungi used in this study. By AFM technique QAG interacted with the fungal surface, altering wall roughness significantly. The probable affinity of fragments of the QAG structure for the fungal enzyme 5I33 (Adenylosuccinate synthetase) has been shown by molecular docking. Low cytotoxicity was observed for polymers (unmodified gum and QAG). The results demonstrate that the quaternized polymer of AG presented in this study is a quite promising biomaterial for biotechnological applications.


Subject(s)
Antifungal Agents , Cytotoxins , Enzyme Inhibitors , Fabaceae/chemistry , Fungal Proteins , Fungi/enzymology , Molecular Docking Simulation , Polysaccharides , Animals , Antifungal Agents/chemistry , Antifungal Agents/pharmacology , Cytotoxins/chemistry , Cytotoxins/pharmacology , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Fungal Proteins/antagonists & inhibitors , Fungal Proteins/chemistry , HEK293 Cells , Humans , Ligases/antagonists & inhibitors , Ligases/chemistry , Mice , Polysaccharides/chemistry , Polysaccharides/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...